Takara Bio Inc
TSE:4974
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Takara Bio Inc
Takara Bio Inc
Accounts Payable
Takara Bio Inc
Accounts Payable Peer Comparison
2160
4587
2929
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Takara Bio Inc
TSE:4974
|
Accounts Payable
¥1.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
GNI Group Ltd
TSE:2160
|
Accounts Payable
¥2.1B
|
CAGR 3-Years
104%
|
CAGR 5-Years
27%
|
CAGR 10-Years
49%
|
|
|
PeptiDream Inc
TSE:4587
|
Accounts Payable
¥3B
|
CAGR 3-Years
197%
|
CAGR 5-Years
103%
|
CAGR 10-Years
77%
|
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Accounts Payable
¥1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
39%
|
CAGR 10-Years
36%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Accounts Payable
¥83.6m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
1%
|
|
S
|
StemRIM Inc
TSE:4599
|
Accounts Payable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Takara Bio Inc's Accounts Payable?
Accounts Payable
1.5B
JPY
Based on the financial report for Mar 31, 2024, Takara Bio Inc's Accounts Payable amounts to 1.5B JPY.
What is Takara Bio Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
0%
Over the last year, the Accounts Payable growth was -34%. The average annual Accounts Payable growth rates for Takara Bio Inc have been -9% over the past three years .
You don't have any saved screeners yet
